Year of treatment as independent predictor of relapse-free survival in patients with localized prostate cancer treated with definitive radiotherapy in the PSA era

International Journal of Radiation Oncology Biology Physics

Volumn 63, Issue 3, 2005, Pages 795-799

  Kupelian, Patrick ^a,b   Thames, Howard ^c   Levy, Larry ^c   Horwitz, Eric ^d   Martinez, Alvaro ^e   Michalski, Jeff ^f   Pisansky, Thomas ^g   Sandler, Howard ^h   Shipley, William ⁱ   Zelefsky, Michael ^j   Zietman, Anthony ⁱ   Kuban, Deborah ^c  

^a M D ANDERSON CANCER CENTER ORLANDO   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d FOX CHASE CANCER CENTER   (United States)

^e WILLIAM BEAUMONT HOSPITAL   (United States)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g MAYO CLINIC   (United States)

^h UNIVERSITY OF MICHIGAN   (United States)

ⁱ MASSACHUSETTS GENERAL HOSPITAL   (United States)

^j MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

more..

Author keywords

Biochemical relapse free survival; Localized prostate cancer; Radiotherapy; Stage migration; Year of therapy

Indexed keywords

BIOPSY; DOSIMETERS; FAILURE ANALYSIS; HORMONES; MULTIVARIABLE SYSTEMS; ONCOLOGY; PATIENT MONITORING; RADIOLOGY; TUMORS;

BIOCHEMICAL RELAPSE-FREE SURVIVAL; LOCALIZED PROSTATE CANCER; STAGE MIGRATION; YEAR OF THERAPY;

RADIOTHERAPY;

ANTIANDROGEN; PROSTATE SPECIFIC ANTIGEN;

ADJUVANT CHEMOTHERAPY; ARTICLE; AWARENESS; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CHEMICAL ANALYSIS; CONTROLLED STUDY; EARLY DIAGNOSIS; FOLLOW UP; GLEASON SCORE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MULTIVARIATE ANALYSIS; PARAMETER; PREDICTION; PRIORITY JOURNAL; PROBABILITY; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY; RADIATION DOSE; RISK FACTOR; SCORING SYSTEM; TREATMENT FAILURE; TUMOR LOCALIZATION;

DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HUMANS; MALE; MULTIVARIATE ANALYSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; TIME FACTORS; TREATMENT OUTCOME;

EID: 25844440888     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2005.03.029     Document Type: Article

References (11)

1. C.L. Amling, M.L. Blute, S.E. Lerner Influence of prostate-specific antigen testing on the spectrum of patients with prostate cancer undergoing radical prostatectomy at a large referral practice Mayo Clin Proc 73 1998 401 406
2. I. Cagiannos, P. Karakiewicz, M. Graefen Is year of radical prostatectomy a predictor of outcome in prostate cancer? J Urol 171 2004 692 696
3. J.O. Ung, J.P. Richie, M.H. Chen Evolution of the presentation and pathologic and biochemical outcomes after radical prostatectomy for patients with clinically localized prostate cancer diagnosed during the PSA era Urology 60 2002 458 463
4. I.H. Derweesh, P.A. Kupelian, C. Zippe Continuing trends in pathological stage migration in radical prostatectomy specimens Urol Oncol 22 2004 300 306
5. F.M. Jhaveri, E.A. Klein, P.A. Kupelian Declining rates of extracapsular extension after radical prostatectomy Evidence for continued stage migration J Clin Oncol 17 1999 3167 3172
6. P.A. Kupelian, J.C. Buchsbaum, M.A. Elshaikh Improvement in relapse-free survival throughout the PSA era in patients with localized prostate cancer treated with definitive radiotherapy Year of treatment an independent predictor of outcome Int J Radiat Oncol Biol Phys 57 2003 629 634
7. D.A. Kuban, H.D. Thames, L.B. Levy Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era Int J Radiat Oncol Biol Phys 57 2003 915 928
8. M. Han, A.W. Partin, S. Piantadosi Era specific biochemical recurrence-free survival following radical prostatectomy for clinically localized prostate cancer J Urol 166 2001 416 419
9. A.W. Partin, L.A. Mangold, D.M. Lamm Contemporary update of prostate cancer staging nomograms (Partin tables) for the new millennium Urology 58 2001 843 848
10. H. Thames, D. Kuban, L. Levy Comparison of alternative biochemical failure definitions based on clinical outcome in 4839 prostate cancer patients treated by external beam radiotherapy between 1986 and 1995 Int J Radiat Oncol Biol Phys 57 2003 929 943
11. P. Kupelian, D. Kuban, H. Thames Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer The combined experience of nine institutions in patients treated in 1994 and 1995 Int J Radiat Oncol Biol Phys 61 2005 415 419